CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,199,950 | -9.7% | 2,654,445 | 0.0% | 0.58% | +32.7% |
| Q2 2023 | $86,587,996 | -5.8% | 2,654,445 | +1.6% | 0.44% | -26.8% |
| Q1 2023 | $91,905,441 | -26.4% | 2,611,692 | -4.2% | 0.60% | -40.0% |
| Q4 2022 | $124,849,282 | -3.5% | 2,724,777 | +2.0% | 1.00% | +20.6% |
| Q3 2022 | $129,441,000 | +8.8% | 2,671,648 | -11.7% | 0.82% | +18.2% |
| Q2 2022 | $118,917,000 | +1.5% | 3,026,648 | -4.9% | 0.70% | +32.2% |
| Q1 2022 | $117,104,000 | -30.0% | 3,181,300 | -13.4% | 0.53% | -15.9% |
| Q4 2021 | $167,368,000 | +55.3% | 3,671,969 | +21.8% | 0.63% | +42.7% |
| Q3 2021 | $107,752,000 | +124.1% | 3,014,882 | +24.1% | 0.44% | +110.5% |
| Q2 2021 | $48,072,000 | -22.6% | 2,429,100 | -9.1% | 0.21% | -45.7% |
| Q1 2021 | $62,148,000 | -8.6% | 2,671,884 | -18.3% | 0.38% | -6.6% |
| Q4 2020 | $67,990,000 | – | 3,271,884 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,721,888 | $41,198,000 | 4.18% |
| Virtus ETF Advisers LLC | 93,309 | $672,000 | 0.58% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 105,324 | $758,000 | 0.55% |
| LANSDOWNE PARTNERS (UK) LLP | 2,647,981 | $19,065,000 | 0.20% |
| WASATCH ADVISORS LP | 1,761,882 | $12,686,000 | 0.16% |
| PINNACLE ASSOCIATES LTD | 888,415 | $6,397,000 | 0.12% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 84,690 | $610,000 | 0.08% |
| Birchview Capital, LP | 10,000 | $72,000 | 0.05% |
| Piermont Capital Management Inc. | 16,530 | $119,000 | 0.04% |
| Tekla Capital Management LLC | 137,797 | $992,000 | 0.04% |